ClinicalTrials.Veeva

Menu

Impact of Fatty Stimuli on Cerebral Activity in Anorexia Nervosa: a Multi-sensory Approach (ANOVERSION)

C

Centre Hospitalier Universitaire de Saint Etienne

Status

Not yet enrolling

Conditions

Anorexia Nervosa

Treatments

Other: MRI examination
Other: Smell and taste capacity testings

Study type

Interventional

Funder types

Other

Identifiers

NCT07344831
24CH172
ANSM (Other Identifier)

Details and patient eligibility

About

Lipid restriction is significant in anorexia nervosa and limits therapeutic management. The multisensory perception of fat is altered, creating an aversion to lipids. The investigators aim to characterize the impact of sensory stimulation (smells or images) associated with specific tastes using neuropsychological assessments and functional MRI. Some volatile aromas can enhance the perception of the associated taste. The investigators hypothesize that such associations are altered in anorexia nervosa for fatty foods but may be preserved for sweet tastes, and that this alteration contributes to the maintenance of the disease. The interdependence of different sensory perceptions of lipids could play a major role in the therapeutic approach, aiding in the deconditioning of this aversion and the restoration of positive food sensory associations.

Enrollment

90 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Person affiliated or entitled to a social security scheme
  • Person having received informed information on the study and having co-signed, with the investigator, a consent to participate in the study
  • female person
  • Person affiliated or entitled to a social security scheme
  • Over 18 years'old
  • Knowing how to read and write French
  • Patient diagnosed with anorexia nervosa according to DSM-5 criteria for at least 5 years (HAS criteria). Failure of prior outpatient or/and hospitalization care over the last 12 months: stable or falling low BMI, unmodified food restriction, continued fear of weight gain, disturbances in the perception of body image
  • BMI < 18.5 kg/m² for volunteers in a state of constitutional thinness. The absence of eating disorder and the absence of restriction to DEBQ questionnaires. Fertility preserved.
  • For volunteers of normal weight: 18.5 kg/m² < BMI < 25 kg/m²

Exclusion criteria

  • Pregnant women, parturient, nursing mothers;
  • Persons deprived of their liberty, hospitalized without consent, hospitalized for purposes other than research;
  • Minors
  • Refusal of the study by the participant
  • Person incapable of giving informed consent
  • Artificial nutrition
  • Associated organic damage favoring undernutrition: other chronic diseases (digestive, infectious, endocrine, pulmonary, cardiac, neurological), neoplasms, etc.
  • Abuse of psychoactive substances except tobacco
  • Characterized depressive episode, psychosis
  • Score less than 14 on the Edinburgh laterality questionnaire.
  • Contraindications to MRI or allergy to one of the components of the olfactory and taste tests
  • Smokers
  • Smell or taste alterations

Trial design

Primary purpose

Basic Science

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

90 participants in 3 patient groups

Anorexia Nervosa patient group
Experimental group
Description:
30 patients with anorexia nervosa
Treatment:
Other: Smell and taste capacity testings
Other: MRI examination
Normal Weight Control group
Active Comparator group
Description:
30 control subjects of normal weight
Treatment:
Other: Smell and taste capacity testings
Other: MRI examination
Low Weight Control group
Active Comparator group
Description:
30 control subjects with a similar weight to AN patients (the constitutional thinness group)
Treatment:
Other: Smell and taste capacity testings
Other: MRI examination

Trial contacts and locations

1

Loading...

Central trial contact

Fabien SCHNEIDER, MD; Florence RANCON, CDP

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems